Literature DB >> 9386022

A randomised controlled comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate.

L A Magee1, G S Dawes, M Moulden, C W Redman.   

Abstract

OBJECTIVE: To compare the effects of maternal administration of betamethasone and dexamethasone on fetal heart rate, using computerised numerical analyses, and to examine the association between changes in short term variation and the timing and indication for delivery.
SETTING: John Radcliffe Hospital, Oxford. SAMPLE: Fifty-nine women with singleton pregnancies, who were at risk of delivery before 34 weeks of gestation, had received no steroids in the preceding week and could give informed consent.
METHODS: Women were randomised on a double-blind basis to receive either betamethasone or dexamethasone. The fetal heart rate was recorded (60-minute duration at similar times of day) before steroid administration and on each of the following two days; changes were measured by computerised analyses. MAIN OUTCOME MEASURES: Changes in short term variation and long term variation of fetal heart rate or the number of fetal movements. Statistical analysis was nonparametric.
RESULTS: Betamethasone and dexamethasone had no differential effects on the computerised cardiotocography. However, both steroids decreased baseline fetal heart rate, increased long term variation, increased short term variation, and decreased fetal movements on the first day after steroid administration, and decreased high fetal heart rate variation and decelerations on the second day. Among 13 women who were delivered within one week of steroid administration, smaller rises in short term variation on day one were associated with delivery for fetal indications.
CONCLUSIONS: Both betamethasone and dexamethasone produced transient, unexplained changes in the fetal heart rate over the two days following steroid administration. Larger changes in short term variation were associated with fetal wellbeing. It is important to recognise that such changes are a physiological response of the human fetus to steroid administration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9386022     DOI: 10.1111/j.1471-0528.1997.tb10968.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  7 in total

Review 1.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Devender Roberts; Julie Brown; Nancy Medley; Stuart R Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2017-03-21

2.  Effect of maternal betamethasone administration on feto-placental vascular resistance in the mouse†.

Authors:  Lindsay S Cahill; Clare L Whitehead; Sebastian R Hobson; Greg Stortz; John C Kingdom; Ahmet Baschat; Kellie E Murphy; Lena Serghides; Christopher K Macgowan; John G Sled
Journal:  Biol Reprod       Date:  2019-10-25       Impact factor: 4.285

Review 3.  Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.

Authors:  Myfanwy J Williams; Jenny A Ramson; Fiona C Brownfoot
Journal:  Cochrane Database Syst Rev       Date:  2022-08-09

Review 4.  Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Fiona C Brownfoot; Caroline A Crowther; Philippa Middleton
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

5.  Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: A randomized trial comparing betamethasone and dexamethasone.

Authors:  Azar Danesh; Mohsen Janghorbani; Shila Khalatbari
Journal:  J Res Med Sci       Date:  2012-10       Impact factor: 1.852

6.  Judicious use of antenatal glucocorticoids: putting the risks into the balance.

Authors:  J Verhaeghe
Journal:  Facts Views Vis Obgyn       Date:  2011

7.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Emma McGoldrick; Fiona Stewart; Roses Parker; Stuart R Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2020-12-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.